Shares of PureTech Health plc (LON:PRTC - Get Free Report) dropped 15.2% on Tuesday . The stock traded as low as GBX 117.20 ($1.53) and last traded at GBX 117.20 ($1.53). Approximately 42,764,352 shares traded hands during trading, an increase of 2,645% from the average daily volume of 1,557,904 shares. The stock had previously closed at GBX 138.20 ($1.81).
Analysts Set New Price Targets
Separately, Jefferies Financial Group reissued a "buy" rating and set a GBX 455 ($5.95) price objective on shares of PureTech Health in a research note on Monday, December 16th.
Check Out Our Latest Research Report on PRTC
PureTech Health Stock Performance
The company has a market cap of £354.45 million, a P/E ratio of -4.84 and a beta of 1.02. The business has a fifty day moving average of GBX 135.24 and a 200 day moving average of GBX 148.09. The company has a quick ratio of 2.51, a current ratio of 3.68 and a debt-to-equity ratio of 45.82.
PureTech Health Company Profile
(
Get Free Report)
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.
Recommended Stories
Before you consider PureTech Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.
While PureTech Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
